[Rituximab as treatment for thrombocytopenic thrombotic purpura associated with systemic lupus erythematosus]

Med Clin (Barc). 2007 Dec 1;129(20):797-8. doi: 10.1157/13113770.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Combined Modality Therapy
  • Cyclophosphamide / therapeutic use
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Infant, Newborn
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / drug therapy
  • Lupus Erythematosus, Systemic / therapy
  • Methylprednisolone / therapeutic use
  • Plasmapheresis
  • Prednisone / therapeutic use
  • Pregnancy
  • Pregnancy Complications / drug therapy
  • Purpura, Thrombotic Thrombocytopenic / drug therapy*
  • Purpura, Thrombotic Thrombocytopenic / etiology
  • Recurrence
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunoglobulins, Intravenous
  • Rituximab
  • Cyclophosphamide
  • Prednisone
  • Methylprednisolone